X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs DIVIS LABORATORIES - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA DIVIS LABORATORIES ABBOTT INDIA/
DIVIS LABORATORIES
 
P/E (TTM) x 33.1 18.5 179.3% View Chart
P/BV x 8.3 4.0 206.9% View Chart
Dividend Yield % 0.8 1.5 52.4%  

Financials

 ABBOTT INDIA   DIVIS LABORATORIES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
DIVIS LABORATORIES
Mar-16
ABBOTT INDIA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs6,0152,484 242.2%   
Low Rs3,707918 403.8%   
Sales per share (Unadj.) Rs1,236.9142.3 869.5%  
Earnings per share (Unadj.) Rs122.241.9 291.7%  
Cash flow per share (Unadj.) Rs129.046.3 278.4%  
Dividends per share (Unadj.) Rs35.0010.00 350.0%  
Dividend yield (eoy) %0.70.6 122.5%  
Book value per share (Unadj.) Rs521.2161.5 322.7%  
Shares outstanding (eoy) m21.25265.47 8.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.912.0 32.9%   
Avg P/E ratio x39.840.6 98.0%  
P/CF ratio (eoy) x37.736.7 102.7%  
Price / Book Value ratio x9.310.5 88.6%  
Dividend payout %28.623.9 120.0%   
Avg Mkt Cap Rs m103,296451,525 22.9%   
No. of employees `0003.03.7 79.7%   
Total wages/salary Rs m3,3703,649 92.3%   
Avg. sales/employee Rs Th8,891.810,184.4 87.3%   
Avg. wages/employee Rs Th1,140.0984.1 115.8%   
Avg. net profit/employee Rs Th878.32,998.5 29.3%   
INCOME DATA
Net Sales Rs m26,28437,764 69.6%  
Other income Rs m504848 59.5%   
Total revenues Rs m26,78938,612 69.4%   
Gross profit Rs m3,66514,138 25.9%  
Depreciation Rs m1441,182 12.2%   
Interest Rs m823 34.9%   
Profit before tax Rs m4,01713,781 29.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4212,662 53.4%   
Profit after tax Rs m2,59611,119 23.4%  
Gross profit margin %13.937.4 37.3%  
Effective tax rate %35.419.3 183.1%   
Net profit margin %9.929.4 33.5%  
BALANCE SHEET DATA
Current assets Rs m14,44630,947 46.7%   
Current liabilities Rs m4,7255,195 90.9%   
Net working cap to sales %37.068.2 54.2%  
Current ratio x3.16.0 51.3%  
Inventory Days Days51117 44.0%  
Debtors Days Days2085 23.0%  
Net fixed assets Rs m1,11317,027 6.5%   
Share capital Rs m213531 40.0%   
"Free" reserves Rs m10,80842,341 25.5%   
Net worth Rs m11,07642,877 25.8%   
Long term debt Rs m05 0.0%   
Total assets Rs m16,24149,684 32.7%  
Interest coverage x497.0595.0 83.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.60.8 212.9%   
Return on assets %16.022.4 71.5%  
Return on equity %23.425.9 90.4%  
Return on capital %36.332.2 112.9%  
Exports to sales %0.685.3 0.7%   
Imports to sales %12.622.9 55.2%   
Exports (fob) Rs m16232,198 0.5%   
Imports (cif) Rs m3,3228,654 38.4%   
Fx inflow Rs m26832,270 0.8%   
Fx outflow Rs m3,9278,775 44.8%   
Net fx Rs m-3,65923,496 -15.6%   
CASH FLOW
From Operations Rs m2,51410,379 24.2%  
From Investments Rs m-800-4,135 19.3%  
From Financial Activity Rs m-803-6,241 12.9%  
Net Cashflow Rs m9123 27,633.3%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 11.8 66.9%  
FIIs % 0.1 19.0 0.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 17.2 99.4%  
Shareholders   18,270 31,796 57.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   AUROBINDO PHARMA  MERCK LTD  NOVARTIS  FULFORD INDIA  ORCHID PHARMA LTD  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 17, 2017 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS